Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOPA-SYN: Carbidopa/Levodopa vs Stalevo in PD
NCT00200447Phase 2Completed
- Sponsor
- Molecular NeuroImaging
- Start
- Mar 2004
- Primary completion
- Sep 2004
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of entacapone in Parkinson's disease (PD), sponsored by Molecular NeuroImaging. Primary endpoint: Reduction from baseline in IBZM striatal uptake. Started Mar 2004; status: completed.
02
Drugs
entacapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00200447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00200447.